280.61MMarket Cap-1965P/E (TTM)
11.3300High10.7381Low239.49KVolume10.9500Open11.1800Pre Close2.62MTurnover0.94%Turnover RatioLossP/E (Static)25.91MShares14.748052wk High2.97P/B276.11MFloat Cap3.888052wk Low--Dividend TTM25.50MShs Float2352.0000Historical High--Div YieldTTM5.29%Amplitude3.8880Historical Low10.9420Avg Price1Lot Size
Inovio Pharmaceuticals Stock Forum
• BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
• Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
• Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...
No comment yet